Gerresheimer AG, a leading provider of healthcare and beauty solutions and drug delivery systems for pharma, biotech and cosmetics, confirms guidance for its financial year 2022 after another quarter of strong and profitable growth. Revenue rose organically by 17.4 per cent in the third quarter, reflecting strong customer demand, leading market positions and the ongoing success of its High Value Solutions. Adjusted EBITDA grew organically by 13.3 per cent.
"Gerresheimer continues on its profitable growth path across all our divisions, business segments and regions reflecting our strong market positions. While steering successfully through a challenging environment, we are consistently pursuing our growth strategy and are boosting our transformation process to become a solution provider and system integrator", said Dietmar Siemssen, CEO of Gerresheimer AG. "We are on track to deliver on our financial year 2022 guidance, and we are clearly committed to our mid-term targets", he affirmed.
Press release:
For further information:
Ueli UtzingerGroup Senior Director Marketing & CommunicationT +49 211 6181-250
This story has been provided by PRNewswire.will not be responsible in any way for the content in this article. (ANI/PRNewswire)
( With inputs from ANI )
Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor